← All Seer, INC filings

Seer, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
SEER
Seer, INC
10-K: Seer Reports 17% Revenue Growth, Reduced Net Loss in 2025
Seer, Inc. announced a 17% increase in total revenue to $16.6 million and a 15% reduction in net loss to $73.6 million for the fiscal year ended December 31, 2025, driven by strong product and service sales.
NASDAQ
SEER
Seer, INC
10-K/A: Seer Inc. Files Amendment to 10-K to Include Part III Information
Seer, Inc. files an amendment to its 2024 annual report to include information required in Part III, related to directors, executive officers, and corporate governance.
NASDAQ
SEER
Seer, INC
10-K: Seer Inc. Reports FY24 Results: Revenue Declines Amid Strategic Realignment
Seer Inc.'s 10-K filing reveals a decrease in revenue for fiscal year 2024, alongside ongoing efforts to commercialize the Proteograph Product Suite and manage operating expenses.
NASDAQ
SEER
Seer, INC
10-K: Seer Inc. Files 10-K Report, Highlights Proteograph Product Suite and Market Strategy
Seer Inc.'s 10-K filing details the company's mission, technology, market strategy, and financial performance for the year ended December 31, 2023, emphasizing the potential of its Proteograph Product Suite.